(Q39916869)

15 September 2017

1 reference

title

Possibilities and Problems of Immunologic Intervention in Cancer (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

4 February 2023

author name string

Smith RT

1

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 August 1972

1 reference

15 September 2017

31 August 1972

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4558044

full work available at URL

4 February 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197208312870905

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The New England Journal of Medicine

4 February 2023

published in

1 reference

15 September 2017

287

1 reference

15 September 2017

439-450

1 reference

15 September 2017

9

1 reference

15 September 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Tumor-Specific Immune Mechanisms

4 February 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cellular Immunity Against Tumor Antigens

4 February 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Immunological Enhancement as Studied by Cell Culture Techniques

4 February 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Journal of the National Cancer Institute

4 February 2023

6

47

vii

Fefer

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

ANTIGENIC PROPERTIES OF HUMAN TUMOURS: DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS

4 February 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon

4 February 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a

4 February 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells

4 February 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells

4 February 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens

4 February 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Effect of leukocytes on transplantability of human cancer

4 February 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Clinical immunologic responsiveness in malignant disease.I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs

4 February 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Impaired immunologic reactivity and recurrence following cancer surgery

4 February 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

18

12

100

Pinsky

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cancer cells in the blood; a five to nine year follow up study

4 February 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Prognostic significance of cancer cells in the circulating blood. A ten year evaluation

4 February 2023

20

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Circulating cancer cells: Pre-and post-chemotherapy observations

4 February 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system

4 February 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

A collaborative study for the evaluation of a serologic test for primary liver cancer

4 February 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Serum alpha-feto-protein and primary cancer of the liver in man.

4 February 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The association of cancer and the nephrotic syndrome

4 February 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The Nephrotic Syndrome: A Prodrome to Lymphoma

4 February 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Nephrotic syndrome in malignant disease of non-renal origin

4 February 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Journal of the National Cancer Institute

4 February 2023

28

39

595

Chu

1967

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Demonstration of cell-bound and humoral immunity against neuroblastoma cells

4 February 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Immune response to urinary bladder tumours in man

4 February 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cellular and humoral immune responses to human urinary bladder carcinomas

4 February 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cellular immunity to nephroblastoma

4 February 2023

34

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium

4 February 2023

35

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Studies on cellular immunity to human neuroblastoma cells

4 February 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Demonstration of cell-mediated immunity to human neoplasms of various histological types

4 February 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia.

4 February 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma

4 February 2023

39

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

In Vitro Responses of Lymphocytes from Cancer-Bearing Patients to Autochthonous Tumor Tissues

4 February 2023

41

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

4 February 2023

42

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens

4 February 2023

43

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

4 February 2023

44

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Sinus histiocytosis and mammary carcinoma. Study of 366 radical mastectomies and an historical review

4 February 2023

45

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Possible host resistance in carcinoma of the breast: a histological study

4 February 2023

46

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

4 February 2023

49

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Journal of the Reticuloendothelial Society

4 February 2023

50

10

137

Morton

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

"Unblocking" serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo

4 February 2023

51

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Journal of the National Cancer Institute

4 February 2023

52

39

1027

Klein

1967

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Possible Explanation for Loss of Detectable Antibody in Patients with Disseminated Malignant Melanoma

4 February 2023

53

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Isolation of a tumor factor responsible for angiogenesis

4 February 2023

55

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

4 February 2023

Federation Proceedings

56

30

648

Gebhardt

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Neuraminidase Activity in HeLa Cells: Effect of Hydrocortisone

4 February 2023

58

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Testicular tumors; a clinicopathological study

4 February 2023

59

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Stromal reaction around tumor and metastasis and prognosis after curative gastrectomy for carcinoma of the stomach

4 February 2023

60

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Studies concerning the regional lymph node in cancer.I. Initiation of immunity

4 February 2023

61

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Effect of autologous tumor extracts on cultured human peripheral blood lymphocytes

4 February 2023

63

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cooperation of Immune Lymphoid Cells with Macrophages in Tumour Immunity

4 February 2023

65

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells

4 February 2023

66

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Microcytotoxicity test: detection in sarcoma patients of antibody cytotoxic to human sarcoma cells

4 February 2023

67

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens

4 February 2023

68

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.

4 February 2023

69

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro

4 February 2023

73

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody

4 February 2023

74

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens

4 February 2023

75

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

In vitro desensitization of sensitized murine lymphocytes by a serum factor (soluble antigen?).

4 February 2023

76

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to moloney sarcomas

4 February 2023

77

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Enhanced growth of primary moloney virus‐induced sarcomas in mice

4 February 2023

80

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils

4 February 2023

81

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer

4 February 2023

82

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Actively acquired tolerance of foreign cells

4 February 2023

84

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Colony inhibition of fibroblasts from chimeric dogs mediated by the dogs' own lymphocytes and specifically abrogated by their serum

4 February 2023

85

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Neonatally induced allograft tolerance may be mediated by serum-borne factors

4 February 2023

86

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Immunological tolerance: "forbidden clones" allowed in tetraparental mice

4 February 2023

87

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Serum-mediated immunological non-reactivity between histoincompatible cells in tetraparental mice.

4 February 2023

90

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Demonstration of an Antigen Common to Several Varieties of Neoplasia

4 February 2023

94

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

95

12

52

Curtis

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Immunotherapy for the Patient with Cancer

4 February 2023

96

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes

4 February 2023

98

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Spontaneous regression of human melanoma: clinical and experimental studies

4 February 2023

99

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Quantitative studies on the mixed lymphocyte interaction in rats. IV. Immunologic potentiality of the responding cells

4 February 2023

100

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Specificity of allogeneic cell recognition by human lymphocytes in vitro

4 February 2023

101

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

102

12

24

Deckers

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

4 February 2023

103

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Effect of Nucleic Acids from Immune Lymphocytes on Rat Sarcomata

4 February 2023

104

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

105

12

86

Helson

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

106

12

2

Prager

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

107

12

66

Lin

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

108

12

47

Bekesi

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG

4 February 2023

109

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Tumor-specific transplantation immunity after cryosurgery

4 February 2023

112

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Enhanced immunogenicity of chemically-coated syngeneic tumor cells

4 February 2023

113

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Active immunotherapy for acute lymphoblastic leukaemia

4 February 2023

117

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells

4 February 2023

118

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

4 February 2023

119

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine Fibrosarcomas

4 February 2023

120

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice.

4 February 2023

122

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli

4 February 2023

123

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)

4 February 2023

125

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis

4 February 2023

126

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

127

12

99

Nathanson

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

128

12

46

Cheema

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Proceedings of the American Association for Cancer Research

4 February 2023

130

12

82

Schlosser

1971

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

Role of thymus-derived lymphocytes in the secondary humoral immune response in mice

4 February 2023

131

1 reference

https://api.crossref.org/works/10.1056/NEJM197208312870905

4 February 2023

Identifiers

1 reference

15 September 2017

1 reference